IP Library Granted Patent US 8,696,568
Granted Patent B2
US 8,696,568 · App. 13/144,605 · Granted Apr 15, 2014

Methods, system and kit for diagnosing and treating dysphagia

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,696,568
App. No.
13/144,605
Granted
Apr 15, 2014
Kind
B2
Abstract

Methods for evaluating and treating patients for dysphagia are provided. In a general embodiment, the method comprises screening the patient for dysphagia symptoms, diagnosing and categorizing the dysphagia if the patient exceeds a threshold of dysphagia symptoms, choosing the proper dysphagia treatment product based the patient's dysphagia, and giving the patient preparation instructions for the dysphagia treatment product.

Claims (34)

1. A method of treating patients having dysphagia, comprising:

screening a patient for a dysphagia risk, the screening comprises scoring a questionnaire based on answers from the patient to the questionnaire, the scoring provides a cumulative point total, and the screening further comprises determining the dysphagia risk of the patient based on the cumulative point total from the questionnaire;

choosing a proper dysphagia treatment product if the cumulative point total exceeds a threshold, and the dysphagia treatment product comprises a component selected from the group consisting of probiotics, vanilloid receptor 1 agonists, angiotensin-conversation enzyme inhibitors, basic tastants, trigeminal stimulants, aromas, salivating agents, thickener compositions, aerated compositions, and combinations thereof;

giving the patient preparation instructions for the dysphagia treatment product; and

wherein the scoring of the questionnaire and the determination of the dysphagia risk are performed using an algorithm implemented by a computer.

2. The method of claim 1 , wherein the questionnaire includes past information relating to dysphagia variables identified by caretaker review, observed variables and self-reported variables.

3. The method of claim 1 , wherein the choosing the proper dysphagia treatment product is based on categorizing the patient based on the cumulative point total from the questionnaire and at least one step selected from the group consisting of:

measuring a force exerted by a tongue of the patient on a soft and/or hard palate;

determining if the airway and the epiglottis of the patient is closing completely;

determining if the airway and the epiglottis timing of the patient is correct;

performing a corn flake test on the patient;

monitoring a tracheal pH of the patient for 24 hours;

performing an ultrasound on the patient to detect abnormal oropharyngeal motor function;

utilizing a deploy preparation tool; and

performing an oral health assessment on the patient.

4. The method of claim 1 , wherein the dysphagia treatment product comprises a probiotic selected from the group consisting of Streptococcus salivarius K12 , Lactobacillus reuteri ATCC55730 , Lactobacillus johnsonii La1 , Lactobacillus plantarum 299v, Lactobacillus rhamnosus GG, Streptococcus thermophilus NCC 1561 , Lactobacillus lactis NCC2211, Lacteol, and combinations thereof.

5. The method of claim 1 , wherein the choosing step is performed by the algorithm.

6. The method of claim 1 , wherein the proper dysphagia treatment product is chosen from a plurality of dysphagia treatment product that each have a different characteristic relative to each other.

7. The method of claim 1 , wherein the patient preparation instructions include following dietary modifications in accordance with dysphagia treatment specifications.

8. A kit for use in a method comprising screening a patient for a dysphagia risk and choosing a proper dysphagia treatment product based on the screening, the kit comprising:

a screening tool that screens the patient for the dysphagia risk, the screening tool comprising a questionnaire and further comprising a screening score system that determines the dysphagia risk of the patient based on a cumulative point total from answers to the questionnaire;

a diagnostic test that categorizes the dysphagia based on the cumulative point total from the questionnaire;

a suggested course of dysphagia treatment based the patient's dysphagia;

instructions for implementing the dysphagia treatment; and

a dysphagia treatment product comprising a component selected from the group consisting of probiotics, vanilloid receptor 1 agonists, angiotensin-conversation enzyme inhibitors, basic tastants, trigeminal stimulants, aromas, salivating agents, thickener compositions, aerated compositions, and combinations thereof.

9. The kit of claim 8 , wherein the dysphagia treatment is a physical therapy regime of the patient based the patient's dysphagia.

10. The kit of claim 9 , wherein the physical therapy regime comprises at least one therapy selected from the group consisting of:

performing specific postural positioning during and after eating; and

performing rehabilitative exercises.

11. The kit of claim 9 , wherein the physical therapy regime is paired with an anabolic nutritional regime.

12. A method of treating patients for dysphagia, the method comprising using an algorithm implemented in a computer program to:

screen a patient for a dysphagia risk by scoring a questionnaire based on answers from the patient to the questionnaire, the scoring providing a cumulative point total, and determining the dysphagia risk of the patient based on the cumulative point total from the questionnaire;

choose a proper dysphagia treatment product if the dysphagia risk exceeds a threshold, the dysphagia treatment product comprising a component selected from the group consisting of probiotics, vanilloid receptor 1 agonists, angiotensin-conversation enzyme inhibitors, basic tastants, trigeminal stimulants, aromas, salivating agents, thickener compositions, aerated compositions, and combinations thereof; and

provide the patient preparation instructions for the dysphagia treatment product.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2011
From: JEDWAB, MICHAEL RUEBEN; ROUGHEAD, ZAMZAM KABIRY; KASPAR, KALA MARIE; SANCHEZ, ARMANDO; HARTMANN, CHRISTOPH; LORET, CHRYSTEL; MARTIN, NATHALIE; ENGMANN, JAN
To: NESTEC S.A.
Reel/Frame 026935/0476 →